Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
37.72
-1.34 (-3.43%)
At close: Mar 3, 2026, 4:00 PM EST
38.20
+0.48 (1.27%)
After-hours: Mar 3, 2026, 7:18 PM EST
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts that cover Soleno Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $109.82, which forecasts a 191.15% increase in the stock price over the next year. The lowest target is $75 and the highest is $145.
Price Target: $109.82 (+191.15%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 4 | 5 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $114 → $110 | Buy | Maintains | $114 → $110 | +191.62% | Feb 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $120 → $85 | Strong Buy | Maintains | $120 → $85 | +125.34% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $106 → $114 | Buy | Maintains | $106 → $114 | +202.23% | Jan 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $120 | Strong Buy | Maintains | $110 → $120 | +218.13% | Jan 20, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $75 | Buy | Initiates | $75 | +98.83% | Nov 18, 2025 |
Financial Forecast
Revenue This Year
492.97M
from 190.41M
Increased by 158.91%
Revenue Next Year
760.14M
from 492.97M
Increased by 54.20%
EPS This Year
4.29
from 0.39
Increased by 1,001.08%
EPS Next Year
7.04
from 4.29
Increased by 63.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 603.0M | 874.2M |
| Avg | 493.0M | 760.1M |
| Low | 406.6M | 645.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 216.7% | 77.3% |
| Avg | 158.9% | 54.2% |
| Low | 113.5% | 31.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 5.97 | 11.11 |
| Avg | 4.29 | 7.04 |
| Low | 3.04 | 5.29 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 1,431.9% | 158.7% |
| Avg | 1,001.1% | 64.0% |
| Low | 679.0% | 23.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.